A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients
Phase of Trial: Phase III
Latest Information Update: 04 Feb 2017
At a glance
- Drugs Fentanyl (Primary) ; Morphine
- Indications Cancer pain
- Focus Registrational; Therapeutic Use
- Sponsors Kyowa Hakko Kirin; Kyowa Hakko Kogyo
- 12 Dec 2013 Manufacturing and marketing approval of Abstral in Japan was received on 20 September 2013, ahead of expectations, and the launch has commenced, according to an Orexo media release.
- 11 Dec 2013 Abstral was launched in Japan, according to a Kyowa Hakko Kirin media release.
- 16 Jun 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History